Dr. Reddy’s Labs announced (in a press release Here) that it has crossed the milestone of $150 million of revenues in the Russia/CIS region for the fiscal year 2009. This milestone is a result of the efforts in building a branded franchise, cementing strong customer relationships and partnering with trade channels over last several years.
Dr. Reddy’s entered the Russia market in 1992 and consolidated its position during the turbulent currency crisis of the late 1990s. As per press release, Dr. Reddy’s is the largest Indian Pharmaceutical company in Russia and is also the fastest growing international branded generic company by volume.
No comments:
Post a Comment